摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,4R)-4-methoxy-2-(methoxymethyl)pyrrolidine | 96304-06-2

中文名称
——
中文别名
——
英文名称
(2S,4R)-4-methoxy-2-(methoxymethyl)pyrrolidine
英文别名
(2S,4R)-2-methoxymethyl-4-methoxypyrrolidine;(2S,4R)-4-hydroxyprolinol dimethyl ether
(2S,4R)-4-methoxy-2-(methoxymethyl)pyrrolidine化学式
CAS
96304-06-2
化学式
C7H15NO2
mdl
——
分子量
145.202
InChiKey
PPTNZOLRDCBYIX-NKWVEPMBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    180.4±25.0 °C(Predicted)
  • 密度:
    0.98±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Influence of 4- or 5-substituents on the pyrrolidine ring of 5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin derivatives on their inhibitory activities towards caspases-3 and -7
    摘要:
    A series of new 4- or 5-substituted pyrrolidine derivatives of 5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin bearing additional n-butyl or 4-fluorobutyl groups at the isatin nitrogen were prepared and their inhibitory activities have been tested against caspases-3 and -7, which are known to participate in the execution of the programmed cell death, called apoptosis. Several analogues fluorinated at the 4-position of the pyrrolidine ring were also synthesized since such inhibitors might be developed as F-18-radiotracers for molecular imaging of activated caspases in vivo by PET. Enantiomerically pure diastereomeric 4-fluoropyrrolidinyl derivatives inhibited the enzymes in the nanomolar scale, i.e.100-1000 times more efficient than the corresponding 4-methoxy analogues. The 4,4-difluorinated compound showed the best result with IC50 = 362 nM and 178 nM for the aforementioned caspases. In contrast, the 4-methoxy and 4-trifluoromethyl analogues exhibited less inhibition potencies for the enzymes in the mu M scale, whereas all 4-OPEG(4) (PEG(4) = tetraethyleneglycol) and 5-methoxymethyl derivatives were inactive. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.04.011
  • 作为产物:
    描述:
    (2S,4R)-N-tert-butyloxycarbonyl-2-methoxymethyl-4-methoxypyrrolidine 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 生成 (2S,4R)-4-methoxy-2-(methoxymethyl)pyrrolidine
    参考文献:
    名称:
    Influence of 4- or 5-substituents on the pyrrolidine ring of 5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin derivatives on their inhibitory activities towards caspases-3 and -7
    摘要:
    A series of new 4- or 5-substituted pyrrolidine derivatives of 5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin bearing additional n-butyl or 4-fluorobutyl groups at the isatin nitrogen were prepared and their inhibitory activities have been tested against caspases-3 and -7, which are known to participate in the execution of the programmed cell death, called apoptosis. Several analogues fluorinated at the 4-position of the pyrrolidine ring were also synthesized since such inhibitors might be developed as F-18-radiotracers for molecular imaging of activated caspases in vivo by PET. Enantiomerically pure diastereomeric 4-fluoropyrrolidinyl derivatives inhibited the enzymes in the nanomolar scale, i.e.100-1000 times more efficient than the corresponding 4-methoxy analogues. The 4,4-difluorinated compound showed the best result with IC50 = 362 nM and 178 nM for the aforementioned caspases. In contrast, the 4-methoxy and 4-trifluoromethyl analogues exhibited less inhibition potencies for the enzymes in the mu M scale, whereas all 4-OPEG(4) (PEG(4) = tetraethyleneglycol) and 5-methoxymethyl derivatives were inactive. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.04.011
点击查看最新优质反应信息

文献信息

  • Zwitterionic Aza-Claisen Rearrangements Controlled by Pyrrolidine Auxiliaries - Useful Key Steps in Convergent Enantioselective Syntheses
    作者:Nora M. Friedemann、Alice Härter、Sebastian Brandes、Steffen Groß、Dorothea Gerlach、Winfried Münch、Dieter Schollmeyer、Udo Nubbemeyer
    DOI:10.1002/ejoc.201200073
    日期:2012.4
    substituents served as efficient auxiliaries in diastereoselective zwitterionic ketene aza-Claisen rearrangements. Palladium-catalysed N-allylation starting from optically active proline and prolinol derivatives, as well as from (2S,5S)-2,5-dimethoxymethylpyrrolidine, gave various allylamines bearing trisubstituted olefin moieties. Treatment with complex carboxylic acid fluorides in the presence of trimethylaluminium
    手性吡咯烷取代基在非对映选择性两性离子烯酮氮杂-克莱森重排中充当有效助剂。从光学活性脯氨酸和脯氨醇衍生物以及 (2S,5S)-2,5-二甲氧基甲基吡咯烷开始,钯催化的 N-烯丙基化得到各种带有三取代烯烃部分的烯丙胺。在三甲基铝诱导活化乙烯酮加成到氮和随后的 [3,3] σ 重排的情况下,用复合羧酸氟化物处理,得到具有优异简单非对映选择性和高达 11:1 辅助诱导非对映体比率的 γ,δ-不饱和酰胺. 吡咯烷酰胺的裂解是通过碘内酯化实现的,可选择回收辅助吡咯烷。通过合适的酰胺和内酯的 X 射线和 NOEDS 分析确定重排和碘环化的立体化学结果。总的来说,两种对映异构体都可以选择性地获得。以这种方式形成的确定构型的旋光酰胺和内酯应可用作会聚甾体天然和药学上重要的产物合成中的关键中间体。
  • New Optically Active 4-Alkoxyprolinol Ethers Derived from trans-4-Hydroxy-L-proline
    作者:Nora M. Friedemann、Astrid Eustergerling、Udo Nubbemeyer
    DOI:10.1002/ejoc.201101156
    日期:2012.2
    (2S,4R)-trans-4-Hydroxy-L-proline has been used as thechiral-pool source in the efficient syntheses of optically active protected 4-hydroxyprolinols. After N-acyl protection andester formation, the first ether moiety was introduced maintaining the chiral centre adjacent to the ester. Then, reduction of the ester delivered the corresponding carbinol, which had to be alkylated selectively to avoid side
    (2S,4R)-trans-4-Hydroxy-L-proline 已被用作手性池源,用于有效合成光学活性保护的 4-羟基脯氨醇。N-酰基保护和酯形成后,引入第一个醚部分,保持与酯相邻的手性中心。然后,酯的还原产生相应的甲醇,必须选择性地将其烷基化以避免与 N-保护基团发生副反应。最后,去除 N-酰基官能团以生成显示定义取代模式的目标甲基和叔丁基醚。如此形成的旋光4-烷氧基脯氨醇醚可用作生物活性化合物中的核心片段或用作合适起始材料中的稳定手性辅助亚单元。
  • Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands
    作者:Jens-Uwe Peters、Torsten Hoffmann、Patrick Schnider、Heinz Stadler、Andreas Koblet、André Alker、Sonia Maria Poli、Theresa M. Ballard、Will Spooren、Lucinda Steward、Andrew J. Sleight
    DOI:10.1016/j.bmcl.2010.04.008
    日期:2010.6
    During a program directed at selective NK1 receptor antagonists, we serendipitously discovered an NK1 receptor ligand with additional affinity for the NK3 receptor. Recognising an opportunity for a drug discovery program aiming for dual NK1/NK3 receptor antagonists, we prepared a series of analogues from a novel, versatile building block. From this series emerged compounds with high and balanced affinities
    在针对选择性NK 1受体拮抗剂的计划中,我们偶然发现了对NK 3受体具有额外亲和力的NK 1受体配体。认识到针对NK 1 / NK 3双重受体拮抗剂的药物开发计划的机会,我们从一种新颖的,通用的构建基块中制备了一系列类似物。从该系列中出现了对NK 1和NK 3受体具有高且平衡亲和力的化合物。口服后,该系列的典型代表在沙土鼠脚踏试验中很活跃。
  • DIASTEREOFACE-DIFFERENTIATING ADDITION OF ORGANOMETALLICS TOWARD CHIRAL α-KETOENAMINES
    作者:Tamotsu Fujisawa、Makoto Watanabe、Toshio Sato
    DOI:10.1246/cl.1984.2055
    日期:1984.12.5
    The diastereoface-differentiating reaction of Grignard reagents or organolithium reagents toward chiral cyclic α-ketoenamines, prepared from the corresponding cycloalkane-1,2-dione and optically active pyrrolidine derivatives, was found to give, after hydrolysis, (R)- or (S)-α-hydroxycycloalkanones, respectively, in high enantiomeric excess.
    由相应的环烷-1,2-二酮和具有光学活性的吡咯烷衍生物制备的格氏试剂或有机锂试剂与手性环α-酮烯胺的非对映异构反应发现,水解后可分别得到对映体过量的(R)-或(S)-α-羟基环烷酮。
  • Piperazine derivatives
    申请人:Take Kazuhiko
    公开号:US20060014948A1
    公开(公告)日:2006-01-19
    This invention relates to piperazine derivatives of the formula: wherein each symbol is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human being or animals.
    这项发明涉及以下式的哌嗪衍生物: 其中每个符号如描述中所定义,并且其药用可接受盐,制备方法,包含相同物质的药物组合物,以及用于治疗或预防人类或动物的Tachykinin介导疾病的用途。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁 阿维巴坦中间体1 阿曲生坦中间体 阿曲生坦 间甲氧基苯乙腈 铂(2+)羟基乙酸酯-吡咯烷-3-胺(1:1:1) 钾2-氧代吡咯烷-1-磺酸酯 钠1-[(9E)-9-十八碳烯酰基氧基]-2,5-二氧代-3-吡咯烷磺酸酯 金刚烷-1-基(吡咯烷-1-基)甲酮 酸-1-吡咯烷-1,4-氨基-2-甲基-1,1,1-二甲基乙基酯,(2S,4R)- 酚丙氢吡咯 试剂3-Mercaptopropanyl-N-hydroxysuccinimideester 西他利酮 血红素酸 螺虫乙酯残留代谢物Mono-Hydroxy 萘吡坦